
CD3+ and CD8+ tumor-infiltrating lymphocytes (TILs) as markers of improved prognosis in high-grade serous ovarian cancer
Kahn, R.M., Matrai, C., Quinn, A.S., Talukdar, N., McIntire, P., Cubillos-Ruiz, J.R., Frey, M.K., Caputo, T.A., Holcomb, K.M., Chapman-Davis, E.Volume:
154
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2019.04.162
Date:
June, 2019
Fichier:
PDF, 115 KB
2019